Company profilePharmaceutical#356 of 1,318 in Pakistan✓ No DRAP alerts

CSH Pharmaceuticals (Pvt.) Ltd.,

Pharmaceutical company · 48 brands · 33 molecules

Ranked #55 of 146 companies in Antiemetics & Antinauseants

48 registered products 50 pharmaceutical brands 33 distinct molecules 0 DRAP alerts

Company overview

48
registered products
50
pharmaceutical brands
33
distinct molecules
6
therapeutic classes
0
DRAP alerts

CSH Pharmaceuticals (Pvt.) Ltd., is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 48 product registrations across 33 distinct molecules. Its portfolio is concentrated in Antiemetics & Antinauseants and Lipid Modifying Agents. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by CSH

25 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

25
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202625

Top molecules by brand count

Amoxicillin20 brands
Ampicillin9 brands
Cefixime4 brands
Amoxicillin ...... 250 Mg3 brands
Atorvastatin2 brands
Amoxicillin ...... 125 Mg2 brands

Therapeutic classes

Antiemetics & Antinauseants · 2Lipid Modifying Agents · 2Antianemic, Iron Preparations · 2Ace Inhibitor · 1Other Mineral Supplements · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official53 products · Rs 44.23 – Rs 922.13
Median across source: Rs 187.61

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MEDIATE PHARMACEUTICALS (PVT) LTD holds 108 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmpicillin BaseAnastrozoleArremether
GETZ PHARMA PAKISTAN (PVT) LTD. holds 269 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
MACTER INTERNATIONAL (PVT) LTD. holds 173 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide

Get the full profile for CSH

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.